April 23, 2021
Business News

Biomarck Pharmaceuticals presents at H.C. Wainwright 2021 Global Life Sciences Conference on March 9-10, 2021

NEWTOWN, Pa.–()–Biomarck Pharmaceuticals, Ltd., a clinical-stage biopharmaceutical company focused on developing peptides that inhibit MARCKS to treat patients with inflammatory diseases, today announced that Dr. Graham G. Lumsden, president and chief executive officer of Biomarck, will present at the H.C. Wainwright 2021 Global Life Sciences Conference, being held March 9-10, 2021.

The presentation will be available to registered conference attendees for on-demand viewing beginning March 9, 2021 at 7:00 a.m. ET and will also be available in the investor section of the company’s website at www.biomarck.com. The webcast will be archived for 60 days following the presentation.

About Biomarck


Click here to view the original article.

Related Posts

You might also like ...

JAB Welcomes Lubomira Rochet as Partner
Cognizant Achieves Guidewire PartnerConnect Cloud Specialization
Netsmart and Vermont Collaborative Launch Care Coordination Platform to Deliver on Data-Driven, Value-Based Care